ALTUV — Bio-UV SA Cashflow Statement
0.000.00%
- €19.85m
- €39.97m
- €39.58m
- 38
- 74
- 65
- 64
Annual cashflow statement for Bio-UV SA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | FAS | FAS | FAS | FAS | FAS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 0.584 | 0.689 | 2.42 | 0.125 | 0.031 |
Depreciation | |||||
Non-Cash Items | 0.03 | 0 | — | 0.236 | — |
Unusual Items | |||||
Changes in Working Capital | -2.57 | -0.367 | -2.61 | 2.48 | 3.56 |
Net Change in Other Assets & Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -0.122 | 3.3 | 2.7 | 6.24 | 6.9 |
Capital Expenditures | -3.02 | -2.73 | -2.22 | -1.96 | -1.94 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | -0.181 | -18 | -6.72 | 0.01 | 0.065 |
Sale of Fixed Assets | |||||
Change in Net Intangibles | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -3.2 | -20.7 | -8.95 | -1.95 | -1.87 |
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 14.3 | 15.5 | -2.5 | -3.57 | -3.73 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 10.9 | -1.73 | -8.82 | 0.731 | 1.39 |